SCHEMBL26533901

SCHEMBL26533901

CC(C)[Si]1(C(C)C)OC[C@H]2O[C@@H](c3scc4c(NC(=O)c5ccccc5)ncnc34)[C@H](OC(=S)n3ccnc3)[C@@H]2O[Si](C(C)C)(C(C)C)O1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26533904 0.83 AURKA (0.31) —
SCHEMBL10457978 0.83 PRMT6 (0.42) —
SCHEMBL26533895 0.77 ACACB (0.33) —
SCHEMBL10459778 0.73 PDE4A (0.42) —
SCHEMBL19880314 0.73 PDE4A (0.42) —
SCHEMBL8923989 0.72 PRMT6 (0.35) —
SCHEMBL10459678 0.72 — —
SCHEMBL9964283 0.72 — —
SCHEMBL25966452 0.71 PRMT6 (0.42) —
SCHEMBL10457977 0.71 PRMT6 (0.40) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11787833-B2 Modified cyclic dinucleoside compounds as sting modulators ALIGOS THERAPEUTICS, INC. (US) 2023-10-17 — — US disclosed
Send feedback